Fig. 2: Kaplan–Meier survival analysis in patients with multiple myeloma who underwent ASCT within one year of diagnosis, stratified by S-phase percentage at the time of transplantation <2% and S-phase ≥2%. | Blood Cancer Journal

Fig. 2: Kaplan–Meier survival analysis in patients with multiple myeloma who underwent ASCT within one year of diagnosis, stratified by S-phase percentage at the time of transplantation <2% and S-phase ≥2%.

From: Impact of residual clonal plasma cells in S-phase at the time of autologous stem cell transplantation on clinical outcomes

Fig. 2

A PFS. B OS. ASCT autologous stem cell transplantation, MM multiple myeloma, PFS progression-free survival, OS overall survival, NR not reached.

Back to article page